JP Morgan Chase
VTVT icon

JP Morgan Chase’s vTv Therapeutics VTVT Stock Holding History

JP Morgan Chase’s Portfolio VTVT Stock Details VTVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3
Closed -$52 – 7688
2025
Q1 		$52 Sell
3
-1,800
-100% -$30.1K ﹤0.01% 6982
2024
Q4 		$24.6K Buy
+1,803
New +$26.7K ﹤0.01% 6212
2024
Q3 		– Sell
-2
Closed -$35 – 7705
2024
Q2 		$35 Hold
2
– – ﹤0.01% 7092
2024
Q1 		$47 Buy
2
+1
+100% +$13 ﹤0.01% 7053
2023
Q4 		$11 Hold
1
– – ﹤0.01% 7414
2023
Q3 		$16 Buy
+1
New +$24 ﹤0.01% 7222
2021
Q3 		– Sell
-76
Closed -$7K – 6839
2021
Q2 		$7K Sell
76
-726
-91% -$73.5K ﹤0.01% 6082
2021
Q1 		$90K Buy
802
+142
+22% +$14K ﹤0.01% 5398
2020
Q4 		$49K Buy
660
+459
+228% +$35.2K ﹤0.01% 5162
2020
Q3 		$15K Buy
201
+3
+2% +$264 ﹤0.01% 5202
2020
Q2 		$17K Buy
+198
New +$19.6K ﹤0.01% 5065
2018
Q2 		– Sell
-8,193
Closed -$1.33M – 5714
2018
Q1 		$1.33M Buy
8,193
+2,938
+56% +$719K ﹤0.01% 3515
2017
Q4 		$1.26M Buy
5,255
+3,187
+154% +$715K ﹤0.01% 3586
2017
Q3 		$481K Buy
+2,068
New +$412K ﹤0.01% 3846
2017
Q2 		– Sell
-135
Closed -$35K – 5248
2017
Q1 		$35K Sell
135
-131
-49% -$29.9K ﹤0.01% 4613
2016
Q4 		$51K Buy
+266
New +$61.1K ﹤0.01% 4546
2016
Q1 		– Sell
-29
Closed -$8K – 4969
2015
Q4 		$8K Buy
+29
New +$8.14K ﹤0.01% 4258

Other funds holding VTVT

SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase's VTVT Position: Q2 2025 in Review

JP Morgan Chase sold out of vTv Therapeutics (VTVT) in Q2 2025, closing a stake of 3 shares — an estimated $52 sold.

JP Morgan Chase first reported a position in VTVT in Q4 2015 and held it in 17 quarters. The position peaked at $1.33M in Q1 2018. 21 funds tracked by Wall St. Rank hold VTVT as of Q2 2025.

  • JP Morgan Chase reported no remaining vTv Therapeutics position as of Q2 2025 after selling out during the quarter.
  • JP Morgan Chase sold 3 vTv Therapeutics shares in Q2 2025, an estimated $52.
  • JP Morgan Chase first reported a position in vTv Therapeutics in Q4 2015 and held it in 17 quarters.
  • JP Morgan Chase's vTv Therapeutics position peaked at $1.33M in Q1 2018.
  • 21 funds tracked by Wall St. Rank held vTv Therapeutics as of Q2 2025.

Based on JP Morgan Chase's 13F filing for Q2 2025, filed 12 Aug 2025.